कुल 50 हाल के अंदरूनी लेनदेन दर्ज हैं Roivant Sciences Ltd. (ROIV), जिसमें शामिल हैं 1 खरीद और 48 बिक्री. कुल अंदरूनी खरीद मूल्य $3.94M और कुल अंदरूनी बिक्री मूल्य $255.11M.
हाल की गतिविधि वाले उल्लेखनीय अंदरूनी लोगों में शामिल हैं Sukhatme Mayukh, Gline Matthew, Torti Frank. अंदरूनी लेनदेन से पता चल सकता है कि कंपनी का नेतृत्व स्टॉक के मूल्यांकन और भविष्य की संभावनाओं को कैसे देखता है.
इनसाइडर ट्रेडिंग — ROIV
| तिथि |
नाम |
भूमिका |
लेनदेन प्रकार |
शेयर |
औसत मूल्य |
मूल्य |
स्वामित्व वाले शेयर |
| 2026-03-31 |
Sukhatme Mayukh |
President & CIO |
RSU कर रोक |
187,512 |
$27.70 |
$5.19M |
18,677,617 |
| 2026-03-31 |
Gline Matthew |
CEO |
RSU कर रोक |
304,684 |
$27.70 |
$8.44M |
17,025,890 |
| 2026-03-31 |
Torti Frank |
President and Vant Chair |
RSU कर रोक |
160,035 |
$27.70 |
$4.43M |
13,576,512 |
| 2026-03-30 |
Sukhatme Mayukh |
President & CIO |
विकल्प प्रयोग (बिक्री) |
1,306,889 |
- |
- |
- |
| 2026-03-30 |
Gline Matthew |
CEO |
विकल्प प्रयोग (बिक्री) |
2,178,150 |
- |
- |
- |
| 2026-03-26 |
Fitzgerald Meghan |
Director |
सूचित बिक्री |
70,000 |
$27.45 |
$1.92M |
42,963 |
| 2026-03-20 |
Pulik Richard |
CFO |
RSU कर रोक |
1,546 |
$27.70 |
$42.82K |
236,867 |
| 2026-03-20 |
Humes Jennifer |
Chief Accounting Officer |
RSU कर रोक |
14,526 |
$27.70 |
$402.37K |
97,729 |
| 2026-03-17 |
Venker Eric |
President & Immunovant CEO |
सूचित बिक्री |
200,000 |
$28.24 |
$5.65M |
1,647,546 |
| 2026-03-16 |
Epperly Melissa B, |
Director |
सूचित बिक्री |
41,861 |
$28.68 |
$1.2M |
15,804 |
| 2026-02-23 |
Torti Frank |
President and Vant Chair |
विकल्प प्रयोग (बिक्री) |
587,390 |
$3.85 |
$2.26M |
3,026,184 |
| 2026-02-20 |
Torti Frank |
President and Vant Chair |
विकल्प प्रयोग (बिक्री) |
1,012,610 |
$3.85 |
$3.9M |
3,613,574 |
| 2026-02-20 |
Venker Eric |
President & Immunovant CEO |
RSU कर रोक |
7,051 |
$27.15 |
$191.43K |
1,647,546 |
| 2026-02-20 |
Pulik Richard |
CFO |
RSU कर रोक |
1,000 |
$27.15 |
$27.15K |
238,413 |
| 2026-02-19 |
Torti Frank |
President and Vant Chair |
विकल्प प्रयोग (बिक्री) |
1,400,000 |
$3.85 |
$5.39M |
4,626,184 |
| 2026-02-13 |
Manchester Keith S |
Director |
सूचित बिक्री |
225,000 |
$26.50 |
$5.96M |
15,127,329 |
| 2026-02-13 |
Qvt Financial Lp |
Other: Director By Deputization |
सूचित बिक्री |
225,000 |
$26.50 |
$5.96M |
15,127,329 |
| 2026-02-13 |
Gold Daniel Allen |
Director |
सूचित बिक्री |
225,000 |
$26.50 |
$5.96M |
15,127,329 |
| 2026-02-13 |
Venker Eric |
President & Immunovant CEO |
सूचित बिक्री |
200,000 |
$26.49 |
$5.3M |
1,654,597 |
| 2026-02-12 |
Manchester Keith S |
Director |
सूचित बिक्री |
275,000 |
$26.76 |
$7.36M |
15,503,113 |
| 2026-02-12 |
Qvt Financial Lp |
Other: Director By Deputization |
सूचित बिक्री |
275,000 |
$26.76 |
$7.36M |
15,503,113 |
| 2026-02-12 |
Gold Daniel Allen |
Director |
सूचित बिक्री |
275,000 |
$26.76 |
$7.36M |
15,503,113 |
| 2026-02-11 |
Manchester Keith S |
Director |
सूचित बिक्री |
425,000 |
$26.67 |
$11.33M |
15,928,113 |
| 2026-02-11 |
Qvt Financial Lp |
Other: Director By Deputization |
सूचित बिक्री |
425,000 |
$26.67 |
$11.33M |
15,928,113 |
| 2026-02-11 |
Gold Daniel Allen |
Director |
सूचित बिक्री |
425,000 |
$26.67 |
$11.33M |
15,928,113 |
| 2026-02-09 |
Sukhatme Mayukh |
President & CIO |
विकल्प प्रयोग (बिक्री) |
651,558 |
$12.68 |
$8.26M |
- |
| 2026-01-20 |
Momtazee James C |
Director |
RSU कर रोक |
122 |
$22.98 |
$2.8K |
109,030 |
| 2026-01-20 |
Oren Ilan |
Director |
RSU कर रोक |
124 |
$22.98 |
$2.85K |
119,428 |
| 2026-01-20 |
Epperly Melissa B, |
Director |
RSU कर रोक |
54 |
$22.98 |
$1.24K |
57,665 |
| 2026-01-12 |
Venker Eric |
President & Immunovant CEO |
सूचित बिक्री |
200,000 |
$21.92 |
$4.38M |
1,654,597 |
| 2025-12-31 |
Sukhatme Mayukh |
President & CIO |
विकल्प प्रयोग (बिक्री) |
2,449,877 |
$12.68 |
$31.06M |
95,718 |
| 2025-12-29 |
Sukhatme Mayukh |
President & CIO |
विकल्प प्रयोग (बिक्री) |
748,358 |
$12.68 |
$9.49M |
555,840 |
| 2025-12-24 |
Torti Frank |
President and Vant Chair |
उपहार (दिया) |
110,489 |
- |
- |
13,736,547 |
| 2025-12-24 |
Venker Eric |
President & Immunovant CEO |
सूचित बिक्री |
75,000 |
$22.53 |
$1.69M |
1,654,597 |
| 2025-12-23 |
Torti Frank |
President and Vant Chair |
RSU पुरस्कार |
175,380 |
$22.45 |
$3.94M |
13,911,927 |
| 2025-12-23 |
Venker Eric |
President & Immunovant CEO |
सूचित बिक्री |
200,000 |
$22.45 |
$4.49M |
1,611,749 |
| 2025-12-23 |
Pulik Richard |
CFO |
सूचित बिक्री |
146,731 |
$22.39 |
$3.29M |
239,413 |
| 2025-12-20 |
Pulik Richard |
CFO |
RSU कर रोक |
2,129 |
$22.41 |
$47.71K |
386,144 |
| 2025-12-17 |
Manchester Keith S |
Director |
सूचित बिक्री |
189,538 |
$23.17 |
$4.39M |
16,353,113 |
| 2025-12-17 |
Qvt Financial Lp |
Other: Director By Deputization |
सूचित बिक्री |
155,076 |
$23.02 |
$3.57M |
16,542,651 |
| 2025-12-17 |
Gold Daniel Allen |
Director |
सूचित बिक्री |
189,538 |
$23.17 |
$4.39M |
16,353,113 |
| 2025-12-17 |
Sukhatme Mayukh |
President & CIO |
विकल्प प्रयोग (बिक्री) |
59,513 |
$12.68 |
$754.62K |
1,304,198 |
| 2025-12-16 |
Manchester Keith S |
Director |
सूचित बिक्री |
642,282 |
$23.08 |
$14.82M |
17,130,445 |
| 2025-12-16 |
Qvt Financial Lp |
Other: Director By Deputization |
सूचित बिक्री |
642,282 |
$23.08 |
$14.82M |
17,130,445 |
| 2025-12-16 |
Gold Daniel Allen |
Director |
सूचित बिक्री |
642,282 |
$23.08 |
$14.82M |
17,130,445 |
| 2025-06-20 |
Ramaswamy Vivek |
10 Percent Owner |
सूचित बिक्री |
577,007 |
$11.46 |
$6.61M |
37,284,108 |
| 2025-06-20 |
Venker Eric |
President & COO |
सूचित बिक्री |
100,000 |
$11.45 |
$1.15M |
1,462,223 |
| 2025-06-20 |
Pulik Richard |
CFO |
RSU कर रोक |
1,503 |
$11.45 |
$17.21K |
399,056 |
| 2025-06-18 |
Ramaswamy Vivek |
10 Percent Owner |
सूचित बिक्री |
565,266 |
$11.45 |
$6.47M |
37,861,115 |
| 2025-06-06 |
Ramaswamy Vivek |
10 Percent Owner |
सूचित बिक्री |
200,800 |
$11.19 |
$2.25M |
38,426,381 |
■ जानकारीपूर्ण — खुले बाजार में खरीद/बिक्री (सर्वाधिक महत्वपूर्ण)
■ गैर-जानकारी खरीद — पुरस्कार, विकल्प अभ्यास, रूपांतरण
■ गैर-जानकारी बिक्री — कर रोक, पुरस्कार बिक्री
■ तटस्थ — उपहार, ट्रस्ट, समाप्ति